The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Net Asset Value(s)

3 Apr 2017 08:13

RNS Number : 3166B
UBS ETF MSCI Emerging Markets A-Dis
03 April 2017
 
COMPANY ID: 121143 
FUND: UBS ETF - MSCI Emerging Markets UCITS ETF (USD) A-dis 
SHORT LISTING NAME: UBS ETF EMMUSA $ 
LONG LISTING NAME: UBS ETF MSCI Emerging Markets A-Dis 
ISIN CODE: LU0480132876 
TRADING CURRENCY: USD 
COB DATE: 31-Mar-2017 
NAV PER SHARE: 94.0545 
BASE CURRENCY: USD 
NUMBER OF SHARES IN ISSUE: 7981359 
ASSETS UNDER MANAGEMENT PER SHARE CLASS: 750682658.69 
ASSETS UNDER MANAGEMENT PER SUBFUND: 771889632.09 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVLIFLDSVIVIID

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.